
Michel Robidoux
businessMale0.0Global Dominance: 0.00%
Michel Robidoux is the president and general manager of Sandoz Canada, a subsidiary of the Swiss generics giant Sandoz Group AG. He has expressed concerns over Health Canada's lengthy drug approval processes, advocating for better harmonization of standards with other countries to expedite access to affordable medications for Canadians.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Michel Robidoux, president and general manager of Sandoz, criticized Health Canada for not harmonizing standards with other countries.
Health Canada taking longer to approve generic drugs, data showThe Globe and Mail·
Canada· 2025-08-05

